Mohamed Gadelkarim
Overview
Explore the profile of Mohamed Gadelkarim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suvilesh K, Manjunath Y, Nussbaum Y, Gadelkarim M, Raju M, Srivastava A, et al.
Clin Cancer Res
. 2024 Jul;
30(17):3855-3867.
PMID: 39017606
Purpose: Systemic treatments given to patients with non-small cell lung cancer (NSCLC) are often ineffective due to drug resistance. In the present study, we investigated patient-derived tumor organoids (PDTO) and...
2.
Gadelkarim M, Alrahmani L, Tonelli C, Freeman R, Raad W, Lubawski Jr J, et al.
JTCVS Open
. 2022 Oct;
12:315-328.
PMID: 36277138
Objectives: The coronavirus disease 2019 (COVID-19) pandemic has changed the landscape of professional activities, emphasizing virtual meetings and social media (SoMe) presence. Whether cardiothoracic programs increased their SoMe presence is...
3.
Gadelkarim M, Elmegeed A, Allam A, Awad A, Shehata M, AbouEl-Enein A, et al.
Joint Bone Spine
. 2022 May;
89(5):105404.
PMID: 35534001
Objective: This research aimed to study the safety and efficacy of adipose-derived mesenchymal stem cells (ADMSCs) for knee osteoarthritis (OA). Methods: We used six databases to search for records and...
4.
Gadelkarim M, Harpole B, Abdelsattar Z
Multimed Man Cardiothorac Surg
. 2022 Feb;
2022.
PMID: 35224900
Enucleation of an esophageal leiomyoma is the treatment of choice in symptomatic patients. Several open or minimally invasive approaches have been shown to be safe and effective. Robotic approaches allow...
5.
Abd-ElGawad M, Abdelmonem M, Ahmed A, Mohammed O, Zaazouee M, Assar A, et al.
BMC Endocr Disord
. 2021 Apr;
21(1):64.
PMID: 33840391
Background: The main purpose is to investigate the effect of LiCO3 as an add-on therapy with radioactive iodine in increasing the cure and decreasing the T4 level compared to radioactive...
6.
Aboshama R, Abdelhakim A, Shareef M, Alamodi A, Sunoqrot M, Alborno N, et al.
J Perinat Med
. 2020 Sep;
49(2):178-190.
PMID: 32950965
Objectives: To compare the safety and efficacy between high dose and low dose oxytocin administration for labor augmentation. Methods: We searched for the available studies during March 2020 in PubMed,...
7.
Menshawy A, Ismail A, Abdel-Maboud M, El-Din A, Elgebaly A, Gadelkarim M, et al.
J Gynecol Obstet Hum Reprod
. 2019 Apr;
48(9):763-770.
PMID: 30940512
Background: Polycystic ovary syndrome (PCOS) is a serious endocrinal disorder in women of reproductive age. Hormonal treatment with oral contraceptives, containing estrogen (ethinyl-estradiol, EE) with progestogen (drospirenone, DRSP) or (chlormadinone...
8.
Gadelkarim M, Abushouk A, Ghanem E, Hamaad A, Saad A, Abdel-Daim M
Biomed Pharmacother
. 2018 Aug;
107:625-633.
PMID: 30118878
With the increasing global prevalence of diabetes mellitus, a significant rise in the number of patients suffering from non-healing wounds is expected. However, available treatments, such as revascularization surgery and...
9.
Menshawy A, Mattar O, Abdulkarim A, Kasem S, Nasreldin N, Menshawy E, et al.
Support Care Cancer
. 2018 Feb;
26(4):1029-1038.
PMID: 29387997
Background: Bone metastasis is reported to be associated with poor quality of life, and increased risk of hospitalization. We aim to synthesize evidence from published randomized controlled trials (RCTs) which...
10.
Ahmed H, Abushouk A, Attia A, Gadelkarim M, Gabr M, Negida A, et al.
J Infect Public Health
. 2017 Oct;
11(2):156-164.
PMID: 28970099
Velpatasvir is a newly FDA-approved inhibitor of hepatitis C virus (HCV) NS5A protein. We performed this systematic review and meta-analysis to investigate the safety and efficacy of velpatasvir plus sofosbuvir...